BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 4022126)

  • 1. Subtle structural alterations in the chains of type I procollagen produce osteogenesis imperfecta type II.
    Bonadio J; Byers PH
    Nature; 1985 Jul 25-31; 316(6026):363-6. PubMed ID: 4022126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered triple helical structure of type I procollagen in lethal perinatal osteogenesis imperfecta.
    Bonadio J; Holbrook KA; Gelinas RE; Jacob J; Byers PH
    J Biol Chem; 1985 Feb; 260(3):1734-42. PubMed ID: 2981871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteogenesis imperfecta type IV: evidence of abnormal triple helical structure of type I collagen.
    Wenstrup RJ; Hunter AG; Byers PH
    Hum Genet; 1986 Sep; 74(1):47-53. PubMed ID: 3759085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type I procollagen in the severe non-lethal form of osteogenesis imperfecta. Defective pro-alpha 1(I) chains in a patient with abnormal proteoglycan metabolism and mineral deposits in the dermis.
    Tenni R; Cetta G; Dyne K; Rossi A; Quacci D; Lenzi L; Castellani AA
    Hum Genet; 1988 Jul; 79(3):245-50. PubMed ID: 3402997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substitution of serine for glycine 883 in the triple helix of the pro alpha 1 (I) chain of type I procollagen produces osteogenesis imperfecta type IV and introduces a structural change in the triple helix that does not alter cleavage of the molecule by procollagen N-proteinase.
    Lightfoot SJ; Atkinson MS; Murphy G; Byers PH; Kadler KE
    J Biol Chem; 1994 Dec; 269(48):30352-7. PubMed ID: 7982948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substitutions of aspartic acid for glycine-220 and of arginine for glycine-664 in the triple helix of the pro alpha 1(I) chain of type I procollagen produce lethal osteogenesis imperfecta and disrupt the ability of collagen fibrils to incorporate crystalline hydroxyapatite.
    Culbert AA; Lowe MP; Atkinson M; Byers PH; Wallis GA; Kadler KE
    Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):815-20. PubMed ID: 7487936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoplasmic reticulum-mediated quality control of type I collagen production by cells from osteogenesis imperfecta patients with mutations in the pro alpha 1 (I) chain carboxyl-terminal propeptide which impair subunit assembly.
    Lamandé SR; Chessler SD; Golub SB; Byers PH; Chan D; Cole WG; Sillence DO; Bateman JF
    J Biol Chem; 1995 Apr; 270(15):8642-9. PubMed ID: 7721766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substitutions for glycine alpha 1-637 and glycine alpha 2-694 of type I procollagen in lethal osteogenesis imperfecta. The conformational strain on the triple helix introduced by a glycine substitution can be transmitted along the helix.
    Tsuneyoshi T; Westerhausen A; Constantinou CD; Prockop DJ
    J Biol Chem; 1991 Aug; 266(24):15608-13. PubMed ID: 1874719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A tripeptide deletion in the triple-helical domain of the pro alpha 1(I) chain of type I procollagen in a patient with lethal osteogenesis imperfecta does not alter cleavage of the molecule by N-proteinase.
    Wallis GA; Kadler KE; Starman BJ; Byers PH
    J Biol Chem; 1992 Dec; 267(35):25529-34. PubMed ID: 1460047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two cysteine substitutions in procollagen I: a glycine replacement near the N-terminus of alpha 1(I) chain causes lethal osteogenesis imperfecta and a glycine replacement in the alpha 2(I) chain markedly destabilizes the triple helix.
    Fertala A; Westerhausen A; Morris G; Rooney JE; Prockop DJ
    Biochem J; 1993 Jan; 289 ( Pt 1)(Pt 1):195-9. PubMed ID: 8424758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on type I collagen in skin fibroblasts cultured from twins with lethal osteogenesis imperfecta.
    Galicka A; Wołczyński S; Gindzieński A
    Acta Biochim Pol; 2003; 50(2):481-8. PubMed ID: 12833172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced secretion of structurally abnormal type I procollagen in a form of osteogenesis imperfecta.
    Barsh GS; Byers PH
    Proc Natl Acad Sci U S A; 1981 Aug; 78(8):5142-6. PubMed ID: 6946461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation in a gene for type I procollagen (COL1A2) in a woman with postmenopausal osteoporosis: evidence for phenotypic and genotypic overlap with mild osteogenesis imperfecta.
    Spotila LD; Constantinou CD; Sereda L; Ganguly A; Riggs BL; Prockop DJ
    Proc Natl Acad Sci U S A; 1991 Jun; 88(12):5423-7. PubMed ID: 2052622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the carboxyl-terminal propeptide of the pro alpha 1(I) chain of type I collagen result in defective chain association and produce lethal osteogenesis imperfecta.
    Chessler SD; Wallis GA; Byers PH
    J Biol Chem; 1993 Aug; 268(24):18218-25. PubMed ID: 8349697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type I procollagen: the gene-protein system that harbors most of the mutations causing osteogenesis imperfecta and probably more common heritable disorders of connective tissue.
    Prockop DJ; Constantinou CD; Dombrowski KE; Hojima Y; Kadler KE; Kuivaniemi H; Tromp G; Vogel BE
    Am J Med Genet; 1989 Sep; 34(1):60-7. PubMed ID: 2683782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A lethal variant of osteogenesis imperfecta has a single base mutation that substitutes cysteine for glycine 904 of the alpha 1(I) chain of type I procollagen. The asymptomatic mother has an unidentified mutation producing an overmodified and unstable type I procollagen.
    Constantinou CD; Nielsen KB; Prockop DJ
    J Clin Invest; 1989 Feb; 83(2):574-84. PubMed ID: 2913053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in PPIB (cyclophilin B) delay type I procollagen chain association and result in perinatal lethal to moderate osteogenesis imperfecta phenotypes.
    Pyott SM; Schwarze U; Christiansen HE; Pepin MG; Leistritz DF; Dineen R; Harris C; Burton BK; Angle B; Kim K; Sussman MD; Weis M; Eyre DR; Russell DW; McCarthy KJ; Steiner RD; Byers PH
    Hum Mol Genet; 2011 Apr; 20(8):1595-609. PubMed ID: 21282188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type I collagen triplet duplication mutation in lethal osteogenesis imperfecta shifts register of alpha chains throughout the helix and disrupts incorporation of mutant helices into fibrils and extracellular matrix.
    Cabral WA; Mertts MV; Makareeva E; Colige A; Tekin M; Pandya A; Leikin S; Marini JC
    J Biol Chem; 2003 Mar; 278(12):10006-12. PubMed ID: 12538651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substitutions for arginine at position 780 in triple helical domain of the α1(I) chain alter folding of the type I procollagen molecule and cause osteogenesis imperfecta.
    Makareeva E; Sun G; Mirigian LS; Mertz EL; Vera JC; Espinoza NA; Yang K; Chen D; Klein TE; Byers PH; Leikin S
    PLoS One; 2018; 13(7):e0200264. PubMed ID: 29990383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defects of type I procollagen metabolism correlated with decrease of prolidase activity in a case of lethal osteogenesis imperfecta.
    Galicka A; Wolczyñski S; Anchim T; Surazyñski A; Lesniewicz R; Palka J
    Eur J Biochem; 2001 Apr; 268(7):2172-8. PubMed ID: 11277941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.